Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Aurora must fill out those forms and apply to get on right away. Otherwise it's all rhetoric nonsense. Why in the hell would they not have everything ready to go when they know it takes a while. They lose credability that way. This is a huge company that has acquired lots of partnerships, should'nt they have all their ducks in a row. What did Cam mean by listing next month. He was praised for being honest and candid. I sincerely hope that he can get us listed in early October like he said, otherwise his credability goes down the toilet. We must get listed ASAP so that big institutions can get permission to invest in Aurora. As long as they are still on the pink sheets it does'nt matter how many billions their market cap holds, major institutions around the world cannot invest even if they wanted to.They are held to certian standards. I wish me and everyone else luck.
Does anyone know if Aurora has already applied to list on US markets yet? If not its going to be a tight squeeze to get in ,in the month of October. And if not, why not yet. They should do it immediately.
All news is good , Just bought another 1000 shares. You know a little here and a little there. Next mega is when uplisting happens along with legalization date. Even my broker bought a ton of Aurora shares and he told me he never buys stock on the pink sheets. But he did his homework and sees this stock going nowhere but UP!He told me he doesnt buy anything on feeling only on stats.
A little dissapionted, you would think with such great earnings this stock would have increased substancially. Also preturbed no mention of Coca Cola, No mention of share dilution,its just that with this kind of dilution aurora would have to make a ton of monies to just go up very little.They must address the dilution problem. They need to start a buyback plan. And Reverand is right they must do something about the shorters if they can. I dont know we will see at close what happens.
Good post John. All looks good. Thanks.
The consencious is a strong buy on Aurora. Two reputable analysts have recomended a strong buy. 10-15. I think the stock will beat previous earnings. Stock goes up. Then all the bells and whistles fall in place and the rest is history. Good luck all.
Starting next week stock should start taking off rapidly. Getting closer to legal date, closer to US listing , maybe drink deal, maybe pharmacutical deal, and all the other partners making monies , we're in the right spot folks. We're in the right spot.
How can this stock be down 1.29 after close.How? Does this mean its gonna open at 8.20 tomorrow marning. I dont get it.
Cabos I enjoy your posts .Keep posting. I look forward to them. They are quite informative and keep me grounded. I can understand you selling off some of your shares cause you have a ton of them. However I really think this stock is going nowhere but up. They have too much invested in this to lose.Theres legalalization coming theres listing on US exchange coming and pharmas , drinks, recs, all sorts of things. I also think they dont need coke, Coke needs them.
On thestreet.com
check out Jim Cramer of CNBC on Aurora , All Good
Watched the interview and was elated to hear about all the good news. However Cam it seemed was a little vague about the dilution question. I didnt quite understand it. Valuation/dilution I sort of get it but still have a question mark. And that interviewer was a little annoying I wish he could just get to the questions and stop patronizing his guests. Just ask the questions and press them for answers. Poriod. In the end I was happy with all Cam said.
This whole politico stuff is a bunch of crap. Lawyers in US say as long as you dont transport it in your vehicle or persons no one can do anything. So there.
Politico's news a lot of BS. We just had a tad bit of correction thats all. I wish I could believe the guy who said he talked to Cam and said they are getting ready to trade of US exchange. That would be the best thing Aurora could do for all.Wish he could have gotten more info from him.No offense . I just think if Cam wanted to he could have put news like that on the website.Anyway for what its worth I hope its true.
If 7.05 holds for the next few days then Aurora will have broken the price barrier and will just take off. There will be no stopping it till the next barrier at 15.00 US.And yes 4000 acres is an aweful lot of land space especially in Europe. Further more its how they use the land and how much they produce from it and at what price that matters most. Believe me folks they are not spending all this monies to lose money. WINNERS!!! Get on this train now!
Clay very informative video. Hope it breakes that 7.05 price and a bull market takes off. Thanks for that.
4000 shares sold is hardly enough to make any kind of a dent in all those outstanding shares. By Friday this stock should be rocking and over the weekend they will disscuss new expansions and investments and partnering etc and boom the stock skyrockets before you can get in. So the oppertunities to buy at these low prices are slowly dissapearing, As Jim Cramer would say Buy Buy Buy!!!!!!!!!!!!!!!
Hunch that came from that article that I posted that the banks are not lending monies to MR companies. Presuming you are right , why the dilution ? Why not use the borrowed monies? I dont get it.The article youo posted was very promising.
d expertise in brands, sales channels and lobbying
The next catalyst for marijuana investors may come from an obvious place: Big Tobacco.
While alcoholic-beverage companies have been active in the marijuana industry, Big Tobacco curiously has not.
But new comments made by an Altria (MO) executive show that the company is evaluating opportunities in marijuana. Altria owns Phillip Morris USA, which makes Marlboro cigarettes. Before digging deeper into the logic of cigarette companies getting into marijuana, let's review marijuana stocks with the help of a chart.
Chart
Please click here (https://thearorareport.com/chart-analysis-of-marijuana-stock-canopy-growth-cgc-tobacco-companies-180909) for an annotated chart of marijuana stock Canopy Growth (WEED.T). Please note the following:
-- The chart shows the sell signal given by The Arora Report in June right at the prior peak. Subsequently the stock lost more than one-third of its value.
-- The chart shows The Arora Report signal to buy Canopy Growth. When The Arora Report gives a buy signal, it simultaneously gives a target zone and a stop zone.
-- The chart shows when Constellation Brands (STZ) known for its Corona beer, invested about $4 billion in the company, paying a whopping premium of 51%.
-- Just prior to the Constellation Brands investment news, Canopy Growth was well on its way to lose one-half of its value from the peak because it reported earnings below the consensus and significantly below the whisper numbers. Stocks move based on the difference between reported earnings and projections compared to the whisper numbers.
-- The start of an "up" move in a stock on heavy volume is considered positive. The chart shows that there was heavy volume when the present up move started.
Ask Arora: Nigam Arora answers your questions about investing in stocks, ETFs, bonds, gold and silver, oil and currencies. Have a question? Send it to Nigam Arora (c:/Users/LOVII/Dropbox/ARTICLES/Nigam@TheAroraReport.com).
-- The chart shows when Canopy Growth stock reached the price that Constellation Brands paid. The chart shows a red candle at that time, indicating that sellers were coming in. This was perfectly reasonable behavior on the part of the sellers because, under normal circumstances, the stock would have likely pulled back.
-- The chart shows that after the red candle, rumors of more deals in the marijuana industry started. Those rumors moved the entire marijuana sector, including marijuana ETF (MJ), Tilray , Neptune Technologies (NEPT.T), Aurora Cannabis , Aphria and Cronos Group (CRON.T).
-- Subsequently, rumors gained credibility on the news that Diageo (DEO), the maker of Smirnoff and Johnnie Walker, was in talks with at least three Canadian cannabis companies.
-- The chart shows the Arora signal to take more partial profits and to raise stops to protect the remaining profits right at the peak of the rumors. Afterward, a shallow pullback occurred. In highly volatile stocks, it is common for unrealized profits to turn into losses. For this reason, the trade-management guidelines that are provided to The Arora Report subscribers call for taking partial profits, usually in small tranches at appropriate times and raising stops. In practice, there are more nuances and more complexities that investors need to learn to consistently make profits than the simple foregoing statement. The foregoing statement is kept simple for the sake of readability.
-- A short squeeze occurs when short-sellers feel compelled to buy a stock to cover their shorts. A short squeeze temporarily causes an exaggerated move to the upside. Anticipating such a short squeeze, the chart shows the Arora buy signal to add for super-aggressive investors. The chart shows that a short squeeze did in fact occur.
-- A technique that consistently adds to profits is to take advantage of a short squeeze to take partial profits. This is exactly what we did as shown on the chart.
-- The chart shows falling volume after the rise. This is a slight negative, indicating that those motivated by FOMO (fear of missing out) may have already bought the stock.
-- The chart shows that the relative strength index (RSI) has diverged. In plain English, it means that while the price of Canopy Growth stock continued to go higher, RSI was going lower. This is normally a sell signal for the short term. Such RSI signals work well in the short term when combined with segmented money flows. However, such signals often mislead investors into selling early when used alone or in strongly trending stocks that have not gone parabolic. Segmented money flows provide investors a significant edge. To learn more about segmented money flows, please see "11 marijuana stocks' money flows show which are investor favorites (http://www.marketwatch.com/story/11-marijuana-stocks-money-flows-show-which-are-investor-favorites-2018-08-16)."
Mixing tobacco with marijuana
Here are the seven reasons why tobacco companies such as Altria, Phillip Morris International (PM), British American Tobacco (BATS.LN), Turning Point Brands (TPB), Alliance One (AOI), Universal Corp. (UVV), Vector Group (VGR) and Imperial Brands ((IMBBY) are likely to get into the marijuana business in a big way.
1. In many ways, the marijuana business is complementary to their existing tobacco business.
2. Cigarette companies are facing declining sales, and they are looking for growth levers. Marijuana is likely to see explosive growth over the coming years.
3. Even supposedly lower-risk tobacco products are beginning to increasingly come under attack for their health risks. In contrast, sentiment is building about the benefits of cannabis, and risks of cannabis are falling in the background.
4. Tobacco companies are rich, and they have the money to get into the cannabis industry.
5. Not too far in the distant future, branding will become a big part of the success in cannabis. Tobacco companies already know how to develop successful brands.
6. Tobacco companies already have huge distribution networks. They can easily add cannabis to those networks down the road. Right now, regulations are not likely to allow this, but tobacco companies are experts at lobbying.
7. Marijuana companies have to deal with a maze of regulations. Tobacco companies are already experts at handling regulations.
What to do now
Tobacco companies will likely provide a big step for marijuana investors to make multimillions. However, investors will need to be patient and be tuned to sources that can alert them early. Further, investors need to be careful with marijuana stocks because of their high valuations and high volatility. Investors will need expert guidance. Without expert guidance, it will likely be easier to lose money in marijuana stocks than make money.
Even with expert guidance, marijuana stocks are not a get-rich-quick proposition. This will not be a straight line up. There will be ups and downs even with expert guidance.
One technique that investors can consider is trade-around positions. In this technique, investors slowly build a core quantity when stock prices become attractive for the long term and then trade around the core position in shorter time frames. Proper diversification will also be important. Learning how to properly size positions will be essential.
In a nutshell, it will take knowledge, discipline and lots of patience on the part of investors to be successful in marijuana investing.
Disclosure: Subscribers to The Arora Report (http://thearorareport.com/) may have positions in the securities mentioned in this article. Nigam Arora is an investor, engineer and nuclear physicist by background who has founded two Inc. 500 fastest-growing companies. He is the founder of The Arora Report, which publishes four newsletters. Nigam can be reached at Nigam@TheAroraReport.com (c:/Users/LOVII/Dropbox/ARTICLES/Nigam@TheAroraReport.com).
-Nigam Arora; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
September 10, 2018 11:05 ET (15:05 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
I think when ACBFF is able to secure loans from major banks instead of diluting its stock to purchase and invest in other companies and expand, it will skyrocket. I also think that when it becomes completely legal, resuming its going to soon. the banks and lending institutions will become more lienient.Then we will see this stock fly. Until then a little here and a little there. In other words LONG.
3 Things to Love About Aurora Cannabis and 1 Thing to Hate
Industry-leading production is just one reason investors can't seem to get enough of this pot stock.
Sean Williams (TMFUltraLong)
Sep 10, 2018 at 7:21AM
The big day is rapidly approaching in Canada. In just 37 days, recreational marijuana will officially be legal for sale to adults aged at least 18 or 19, depending on the province, in licensed dispensaries. And with this legalization comes the potential for the industry to add in the neighborhood of $5 billion in annual sales, once at full capacity, atop what it's been generating from domestic medical cannabis sales and via exports.
Three things to love about Aurora Cannabis
Not surprisingly, marijuana stocks have been off to the races in advance of this Oct. 17 launch. One pot stock in particular that investors can't seem to get enough of is Aurora Cannabis (NASDAQOTH:ACBFF). Sporting a $6 billion market cap, Aurora Cannabis currently slides in as the third-largest publicly traded pot stock, and clearly one of the most active by average trading volume.
What is it about Aurora Cannabis that makes it so special? Let's take a closer look at three things investors probably love about the company.
Jars filled with cannabis laid out on a counter.
IMAGE SOURCE: GETTY IMAGES.
1. Its (expected) industry-leading production
Easily one of the most appealing aspects of Aurora Cannabis is the company's estimated peak production of 570,000 kilograms, when at full capacity. Although Canopy Growth Corp. hasn't divulged a peak production estimate like most pot stocks, there's a decent shot that Aurora Cannabis locks up the top spot as Canada's leading cannabis producer.
Aurora has been exceptionally aggressive with its capacity expansion, catapulting from a little more than 100,000 kilograms in peak annual production at the beginning of the year to about 570,000 kilograms by July. And it's done so organically, via strategic partnership, and by acquisition.
The company's Aurora Sky project was a completely organic build spanning approximately 800,000 square feet, with an expected annual yield of at least 100,000 kilograms, and its ongoing Aurora Sun project in Alberta will span 1.2 million square feet and yield 150,000 kilograms a year when complete. Then there's Aurora's partnership with Alfred Pedersen & Son in Denmark, known as Aurora Nordic, which will produce around 120,000 kilograms per year when fully operational. Lastly, there were the acquisitions of CanniMed Therapeutics and MedReleaf.
Being the top marijuana producer should come with perks, such as strong pricing power, and the desire of provinces and retailers to negotiate in long-term supply deals with Aurora Cannabis.
A bottle of softgel capsules tipped over on a table, with about a dozen capsules piled in front of the bottle.
IMAGE SOURCE: GETTY IMAGES.
2. The company's high-margin focus and international expansion
Secondly, investors have to be impressed with Aurora Cannabis' unique focus on medical cannabis as recreational legalization looms, as well as its continued push into foreign markets.
With the floodgates about to open, you'd think most growers are readying to focus on adult-use demand -- but that's not in Aurora's game plan. The issue with the recreational market is that dried flower could be easily commoditized, which would wreak havoc on marijuana stock margins, despite economies of scale working in favor of growers. Though we have little precedence to speak of, oversupply has crushed the per-gram price of cannabis in Colorado, Washington, and Oregon, and it's starting to do the same in California. There's a good chance that Canadian growers that focus too heavily on the recreational market could run into similar issues.
By focusing on the medical marijuana market domestically and abroad, Aurora Cannabis is narrowing its pool of prospective consumers but is also securing its pricing power and substantially reducing the possibility of commoditization. It's a smart move to supercharge its longer-term margins.
Aurora will primarily be looking at the roughly 30 countries worldwide that have legalized medical weed in some capacity as its key sources of revenue. Its Aurora Nordic facility in Denmark is expected to be a primary production source for Scandinavia, Denmark, and perhaps other relatively local European countries.
An indoor commercial cannabis grow facility.
IMAGE SOURCE: GETTY IMAGES.
3. Its diverse revenue stream
Thirdly, investors have to appreciate the diversity of Aurora Cannabis' revenue stream, which is about much more than just dried cannabis.
As noted, the company will be angling to become a major medical marijuana player globally. As such, it's been working to bolster its product offerings to patients, including oils. In June, Aurora invested 10 million Canadian dollars into Capcium (a 19.99% equity stake) to develop a line of softgel capsules for medical marijuana patients. Though Capcium is working on its own commercial-scale facility, it won't be completed until the fourth quarter of next year. As such, Aurora is allowing Capcium to produce softgel capsules at its Aurora Vie facility in the interim.
Beyond production, Aurora also acquired Larssen in November 2017. Larssen is involved in the design and construction of greenhouses around the globe. Having previously been commissioned for a handful of Aurora's greenhouses, the company decided to gobble up Larssen and internalize its construction and retrofit costs. It also gives Aurora an opportunity to benefit from the expansion and legalization of pot worldwide. Consider this a great means of diversifying its revenue stream even further away from dried cannabis.
A magnifying glass held over a company's balance sheet.
IMAGE SOURCE: GETTY IMAGES.
And the one thing you should hate about Aurora Cannabis
On the other hand, one of investors' favorite marijuana stocks has a very big flaw: dilution.
Prior to the passage of the Cannabis Act, marijuana companies had virtually no access to basic banking services, such as a line of credit, a loan, or even a checking account. Banks feared the possibility of financial and/or criminal penalties if they offered their services to pot-based businesses. This left marijuana stocks like Aurora Cannabis with one solution: turn to bought-deal offerings.
A bought-deal offering involves the sale of common stock, convertible debentures, stock options, and/or warrants in order to raise capital. Truth be told, domestic cannabis sales and exports aren't generating anywhere near enough positive operating cash flow to pay for ongoing capacity expansion projects or acquisitions. As such, companies like Aurora turned to issuing shares like they were going out of style to pay for its transformation.
Since the end of fiscal 2014, Aurora's outstanding share count has ballooned from just over 16 million to around 950 million. With a number of existing convertible notes, stock options, and warrants still outstanding, it's almost assured that Aurora's share count will surpass 1 billion. Aside from weighing down existing shareholders for a long period of time, it also means that Aurora needs to generate CA$100 million just to produce CA$0.10 in earnings per share, which would still represent a nosebleed price-to-earnings ratio of 81.
In other words, Aurora may have clear-cut advantages and things to like, but it's sort of a nightmare from a fundamental and investing perspective.
Just doubled my position today . Good things are comming. I just know it.
dustry Companies Present September 12
8:35 am ET September 6, 2018 (PR Newswire) Print
Cannabis company executives share vision, answer questions live at VirtualInvestorConferences.com
VirtualinvestorConferences.com and KCSA Strategic Communications today announced the agenda for the upcoming VirtualInvestorConferences.com, the evergreen online investor conference series. Individual investors, institutional investors, advisors, and analysts are invited. The show opens at 9:45 AM ET, with the first live webcast at 10:00 AM ET, on Wednesday, September 12th.
https://mma.prnewswire.com/media/195276/virtual_investor_conferences_logo.jpg
REGISTER NOW: https://tinyurl.com/912CannabisVIC
Pre-registration is suggested to save time: There is no fee for anyone to log-in, attend the live presentations and ask questions.
September 12th Agenda
10:00 AM ET LiveWell Canada Inc. OTC: LXLLF
David Rendimonti, President CSE: LVWL
10:30 AM ET Medicine Man Technologies Inc. OTCQB: MDCL
Brett Roper, Co-Founder and CEO
11:00 AM ET KushCo Holdings Inc. OTCQB: KSHB
Jim McCormick, CFO and COO
11:30 AM ET iAnthus Capital Holdings, Inc. OTCQB: ITHUF
Hadley Ford, CEO CSE: IAN
12:00 PM ET Aurora Cannabis Inc. OTCQB: ACBFF
Cam Battley, Chief Corporate Officer TSX: ACB
12:30 PM ET Golden Leaf Holdings Ltd. OTCQB: GLDFF
William Simpson, CEO CSE: GLH
1:00 PM ET Terra Tech Corp. OTCQX: TRTC
Derek Peterson, Chairman and CEO
1:30 PM ET CordovaCann Corp. OTCQB: LVRLF
Taz Turner, CEO CSE: CDVA
2:00 PM ET Khiron Life Sciences Corp. OTCQB: KHRNF
Chris Naprawa, President TSXV: KHRN
2:30 PM ET The Green Organic Dutchman Holdings Ltd. OTCQB: TGODF
Danny Brody, Vice President - Investor Relations TSX: TGOD
Learn More about the Event: To facilitate investor relations scheduling and budgeting, more information, including a full calendar of VirtualInvestorConferences.com dates is available at: http://virtualinvestorconferences.c
Aurora's market cap is healthy. For a stock trading between 6 and 7 Thats pretty good we're not that far off from Tilray whose trading in the fifties. NO one ,No One would risk that kind of monies if they did'nt have a concrete plan to capitalize not Aurora and not the banks and not even the companies that Aurora has interests in. Think about that we're talking a lot of monies here.Also these companies cant wait for offers from Aurora to jump on board.The only thing that I have a problem with is why Aurora is not even trying to do any share buybacks to reduce the outstanding shares.But I have to trust that it will happen soon.Does any one know if they have applied to get on Nasdaq or NYSE? Maybe we should call investor relations at Aurora and pose all our questions. You can do that you know!We'll see what happens this week.Stay strong.
You are 100 % right Hunch. No one is going to loan you that kind of money without doing a thorough check to make sure you can pay it back and will be profitable looking forward. If it's good for the banks it's good for me. With that said I still thing this stock is a little laggard. News like this should have given it quite the boost.
You are 100% right. It's not getting a boost without getting on either NYSE or Nasdaq. Maybe there is something not quite right that they are not telling us.You dont hear them addressing this issue too much and quite a few investors want to know why. They just kinda skim over that question vaguely. Don't know what's up with that.
Even with all this good news we are still headed south. I tell you this stock is not going to break out unless it is on Nasdaq or nyse the only two credible venues. O r another company invests in the heavy will give them momentum. Every thing else is rhetoric bullshit. Getting really annoyed with Aurora. It needs to breakout already. So much of telling us what they are going to do all positive and the stock is in stroking mode. Paleez!
talking about Aurora.s market cap
Aurora's almost as much as tlry if not more yet tilray at 58 aurora under 7. What up with that?.By the way they didnt beat earnings they just narrowed the loss. Their revenue imploded though.Gosh wish Aurora was on Nasdaq, just dont understand what the hell they are waiting for. So frustrating.
Chicago P.try Libya. LOL!
Bought more shares today however still a little apprehensive about the 1 billion outstanding shares. I wish Aurora would start doing some buy back. It will make the stock more appealing and attract a lot of large cap companies.Its bothersome to me that everytime an alcohol company comes afloat it selects another cannibus company to invest in. Or maybe Aurora just will not agree to be under anyone's thumb. Which is a good thing to always be in control, I cant blame them. I just keep buying at every opportunity. I truly believe in Aurora.
Expresso 123 execellent video on diaego they actually said they are talking to aurora. They are huge.
Thanks Chicago Paul that was a very settling video.
Report says Smirnoff maker is looking for pot partner, after $4 billion investment in Canopy by booze giant Constellation
Marijuana stocks were on a rampage Friday, after a report that Smirnoff and Johnnie Walker maker Diageo PLC is in talks with at least three Canadian pot companies with the intent to purchase a stake or initiate a collaboration in one of them, part of a wave of large traditional companies looking to partner with cannabis companies.
I cannot understand why these alcohol companies are not tapping Aurora for a deal. It's not like there's a lot of companies producing marijuana right now. You'd think they were breaking down the doors.
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aurora Cannabis Inc. (OTC:ACBFF), Canopy Growth Corporation (NYSE:CGC), MobileIron, Inc. (NASDAQ:MOBL), Sangamo Therapeutics, Inc. (NASDAQ:SGMO), BioDelivery Sciences International, Inc. (NASDAQ:BDSI), and First Solar, Inc. (NASDAQ:FSLR), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
ACBFF DOWNLOAD: http://Fundamental-Markets.com/register/?so=ACBFF
CGC DOWNLOAD: http://Fundamental-Markets.com/register/?so=CGC
MOBL DOWNLOAD: http://Fundamental-Markets.com/register/?so=MOBL
SGMO DOWNLOAD: http://Fundamental-Markets.com/register/?so=SGMO
BDSI DOWNLOAD: http://Fundamental-Markets.com/register/?so=BDSI
FSLR DOWNLOAD: http://Fundamental-Markets.com/register/?so=FSLR
(You may have to copy and paste the link into your browser and hit the [ENTE
8:10 am ET
Factors of Influence in 2018, Key Indicators and Opportunity within Aurora Cannabis, Canopy Growth, MobileIron, Sangamo Therapeutics, BioDelivery Sciences International, and First Solar -- New Research Emphasizes Economic Growth
Globe Newswire
I just bought a lot more. Things are looking quite good.
Seems like something is brewing for a takeoff. Just bought a ton more shares today . Did'nt want to get left out of this one. Hoping I did the right thing here.
Sorry Mind I stand corrected. Just saw that date on the link you posted. Sorry,but still I dont like the delay.
Mind this is not the same thing as I have posted.Re-read. The delay to April 1, especially.